These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8099753)

  • 41. Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat.
    Ishikawa S; Schrier RW
    J Clin Invest; 1982 Mar; 69(3):666-72. PubMed ID: 6174549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioid control of oxytocin secretion: evidence of distinct regulatory actions of two opiate receptor types.
    Carter DA; Lightman SL
    Life Sci; 1987 Jun; 40(23):2289-96. PubMed ID: 3035309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential inhibitory action by morphine on the release of oxytocin and vasopressin from the isolated neural lobe.
    Clarke G; Patrick G
    Neurosci Lett; 1983 Aug; 39(2):175-80. PubMed ID: 6633948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential regulation of oxytocin- and vasopressin-secreting nerve terminals.
    Bicknell RJ; Leng G
    Prog Brain Res; 1983; 60():333-41. PubMed ID: 6665149
    [No Abstract]   [Full Text] [Related]  

  • 45. Naloxone-induced supersensitivity of oxytocin neurones to opioid antagonists.
    Carón RW; Leng G; Ludwig M; Russell JA
    Neuropharmacology; 1998 Jul; 37(7):887-97. PubMed ID: 9776384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stimulus-induced depletion of pro-enkephalins, oxytocin and vasopressin and pro-enkephalin interaction with posterior pituitary hormone release in vitro.
    Leng G; Bicknell RJ; Brown D; Bowden C; Chapman C; Russell JA
    Neuroendocrinology; 1994 Dec; 60(6):559-66. PubMed ID: 7700499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of opioid antagonism and environmental restriction on plasma oxytocin and vasopressin concentrations in parturient gilts.
    Jarvis S; Lawrence AB; McLean KA; Chirnside J; Deans LA; Calvert SK; Gilbert CL; Goode JA; Forsling ML
    J Endocrinol; 2000 Jul; 166(1):39-44. PubMed ID: 10856881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Naloxone potentiates the release of oxytocin induced by systemic administration of cholecystokinin without enhancing the electrical activity of supraoptic oxytocin neurones.
    Leng G; Dyball RE; Way SA
    Exp Brain Res; 1992; 88(2):321-5. PubMed ID: 1577106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endogenous opioids inhibit oxytocin release during nicotine-stimulated secretion of vasopressin in man.
    Seckl JR; Johnson M; Shakespear C; Lightman SL
    Clin Endocrinol (Oxf); 1988 May; 28(5):509-14. PubMed ID: 3214943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition by morphine and beta-endorphin of vasopressin release evoked by electrical stimulation of the rat medial basal hypothalamus in vitro.
    Knepel W; Reimann W
    Brain Res; 1982 Apr; 238(2):484-8. PubMed ID: 6284302
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of ACTH on opiate inhibition of oxytocin release.
    Wright DM; Pill CE; Clarke G
    Life Sci; 1983; 33 Suppl 1():495-8. PubMed ID: 6141496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endogenous opioids regulate intracerebral oxytocin release during parturition in a region-specific manner.
    Neumann I; Russell JA; Landgraf R
    Prog Brain Res; 1992; 91():55-8. PubMed ID: 1410433
    [No Abstract]   [Full Text] [Related]  

  • 53. Dopaminergic modulation of evoked vasopressin release from the isolated neurohypophysis of the rat. Possible involvement of endogenous opioids.
    Racké K; Ritzel H; Trapp B; Muscholl E
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):56-65. PubMed ID: 7110370
    [No Abstract]   [Full Text] [Related]  

  • 54. Stimulation of the hypothalamic paraventricular nucleus produces analgesia not mediated by vasopressin or endogenous opioids.
    Yirmiya R; Ben-Eliyahu S; Shavit Y; Marek P; Liebeskind JC
    Brain Res; 1990 Dec; 537(1-2):169-74. PubMed ID: 1982239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opioid peptides in the hippocampus: anatomical and physiological considerations.
    Henriksen SJ; Chouvet G; McGinty J; Bloom FE
    Ann N Y Acad Sci; 1982; 398():207-20. PubMed ID: 6130736
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of naloxone and opioid agonists on gastric excitatory responses to stimulation of the vagus nerve in cats.
    Okamoto T; Kurahashi K; Fujiwara M
    Br J Pharmacol; 1988 Oct; 95(2):329-34. PubMed ID: 2906554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of adrenoreceptors in the regulation of oxytocin and vasopressin release after superior cervical ganglionectomy.
    Lipińska S
    J Physiol Pharmacol; 2000 Mar; 51(1):111-25. PubMed ID: 10768855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of VP and OT release by water in hypovolemia is independent of opioid peptides.
    Rosella-Dampman LM; Hartman RD; Summy-Long JY
    Am J Physiol; 1987 Jul; 253(1 Pt 2):R31-8. PubMed ID: 3605388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of response in the release of oxytocin and vasopressin from isolated neurohypophyses to dopamine, met-enkephalin and leu-enkephalin.
    Pitzel L; König A
    Exp Brain Res; 1984; 56(2):221-6. PubMed ID: 6090193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Naloxone excites oxytocin neurones in the supraoptic nucleus of lactating rats after chronic morphine treatment.
    Bicknell RJ; Leng G; Lincoln DW; Russell JA
    J Physiol; 1988 Feb; 396():297-317. PubMed ID: 2900890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.